Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Acetylcholinesterase ELISA Kit (AC3159)
Cat.#: ASET-1748
Specifications
Description Rat Acetylcholinesterase ELISA Kit allows for the in vitro quantitative determination of rat Acetylcholinesterase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1279 Human SLC25A12 ELISA Kit (AC2690) Quantitative inquiry ASET-2035 Mouse CD11b ELISA Kit (AC3446) Quantitative inquiry ASET-1379 Human CD11b ELISA Kit (AC2790) Quantitative inquiry ASET-1432 Human PER2 ELISA Kit (AC2843) Quantitative inquiry ASET-1912 Rat NMDAR1 ELISA Kit (AC3323) Quantitative inquiry ASET-2429 Human PPAR gamma ELISA Kit (AC3840) Quantitative inquiry ASET-1634 Human Adenosine Receptor A2a ELISA Kit (AC3045) Quantitative inquiry ASET-1234 Rat beta Catenin ELISA Kit (AC2645) Quantitative inquiry ASET-1069 Human FGFR1 ELISA Kit (AC2480) Quantitative inquiry ASET-1575 Human KCNK9 ELISA Kit (AC2986) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket